News

Treatment options for patients with moderately to severely active Crohn's disease have expanded in the past decade, with ...
In a major advance for patients with Crohn's disease, a new study led by researchers at Mount Sinai Health System found that ...
In a major advance for patients with Crohn's disease, a new study led by researchers at Mount Sinai Health System found ...
Peter Mac researchers have discovered a powerful new drug combination that could offer hope to children and adults with ...
Dr. Zuraw led clinical development of telitacicept across MG, Sjögren’s, SLE, and RA at RemeGen, resulting in multiple ...